期刊文献+

多项联合检测在肺腺癌与鳞癌鉴别诊断中的价值 被引量:4

Value of multiple joint detection in the differential diagnosis of lung adenocarcinoma and squamous cell carcinoma
下载PDF
导出
摘要 目的探讨p40、天冬氨酸蛋白酶A(novel aspartie proteinase A,Napsin A)及甲状腺转录因子(thyroid transcription factor-1,TTF-1)联合检测在肺腺癌与鳞癌鉴别诊断中的价值。方法分析于本院行肺癌手术的41例腺癌和30例鳞癌患者p40、Napsin A及TTF-1的表达,结合临床病理资料进行统计分析。结果p40在腺癌中不表达,在鳞癌中的阳性率为100%。TTF-1在腺癌中的阳性率为80.48%,显著高于鳞癌的7.69%(P<0.05),Napsin A在鳞癌中不表达,在腺癌中的阳性率为95.12%,显著高于TTF-1(P<0.05)。在腺癌中Napsin A和TTF-1在伴有淋巴结转移的、TNM分期Ⅲ-Ⅳ期的患者中的阳性率显著高于无转移、Ⅰ-Ⅱ期的患者(P<0.05);对鳞癌患者,在伴有淋巴结转移的TTF-1的阳性率显著高于无转移的患者(P<0.05)。Napsin A单指标检测诊断腺癌的敏感性为88.57%,特异性为94.41%,TTF-1单指标检测诊断腺癌的敏感性为80.49%,特异性为92.31%,均低于Napsin A。两者联合检测的敏感性为96.13%,特异性为100%,高于单指标检测。结论 p40、Napsin A及TTF-1的检测是鳞癌、腺癌鉴别诊断的有力依据,Napsin A和TTF-1的表达有助于预测患者的预后,联合检测能提高腺癌诊断的准确性。 Objective To investigate the clinical significance of joint detection of p40,novel aspartie proteinase A( Napsin A) and thyroid transcription factor-1( TTF-1) in the differential diagnosis of lung adenocarcinoma and squamous cell carcinoma.Methods The expressions of P40,Napsin A and TTF-1 in 41 patients with adenocarcinoma and 30 patients with squamous cell carcinoma were analyzed.Statistical analysis was done combined with clinicopathological data.Results p40 did not express in adenocarcinoma patients,but it was 100% positive in squamous cell carcinoma.The positive rate of TTF-1 in adenocarcinoma was 80.48%,which was significantly higher than7.69% in squamous cell carcinoma( P〈0.05).Napsin A did not express in squamous cell carcinoma,but its positive rate of Napsin A in adenocarcinoma was 95.12%,which was significantly higher than that of TTF-1( P〈0.05).In adenocarcinomas,the positive rate of Napsin A and TTF-1 in patients with lymph node metastasis or in TNM stage Ⅲ-Ⅳ were significantly higher than those in patients without metastasis,stage I-II( P〈0.05).In squamous cell carcinoma patients,the positive rate of TTF-1 with lymph node metastasis was significantly higher than that of patients without metastatic( P〈0.05).In adenocarcinoma,the sensitivity of Napsin A was 88.57%,and the specificity was 94.41%,while the sensitivity of TTF-1 was 80.49%,and the specificity was 92.31%,which were both lower than Napsin A.The sensitivity and specificity of the joint detection was 96.13% and 100%,higher than the single-index test.Conclusion The detection of p40,Napsin A and TTF-1 is a powerful basis for the differential diagnosis of squamous cell carcinoma and adenocarcinoma.The expression of Napsin A and TTF-1 is helpful to predict the prognosis of patients,and the combined detection can improve the diagnostic accuracy of adenocarcinoma.
作者 叶宗媛 何俊 王健 张秀珊 张武霞 张鹏飞 童砚 YE Zong-yuan;HE Jun;WANG Jian;ZHANG Xiu-shan;ZHANG Wu-xia;ZHANG Peng-fei;TONG Yan(Department of Pathology,Hefei First People's Hospital,Hefei,Anhui 230061,China)
出处 《临床肺科杂志》 2018年第10期1874-1877,1890,共5页 Journal of Clinical Pulmonary Medicine
关键词 P40 NapsinA TTF-1 病理 肺癌 鉴别诊断 p40 NapsinA TTF-1 pathology lung cancer differential diagnosis
  • 相关文献

参考文献4

二级参考文献34

  • 1Rami-Porta R,Ball D,Crowley J,et al.The IASLC Lung Cancer Staging Project:Proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer[J].J Thorac Oncol,2007,2(7):593-602.
  • 2Ruseh VW,Crowley J,Giroux DJ,et al.The IASLC Lung Cancer Staging Project:Proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer[J].J Thorac Oncol,2007,2(7):603-612.
  • 3Pisters KM,Darling G.The IASLC Lung Cancer Staging Project:"the nodal zone"[J].J Thorac Oncol,2007,2(7):583-584.
  • 4Senan S.staging nodal disease in non-small cell lung cancer:Implications for radiation therapy[J].J Thorac Oncol,2007,2(7):585-587.
  • 5Pao W, Miller V, Zakowski M, et al. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib [ J]. Proc Natl Acad Sci U S A, 2004, 101(36): 13306-13311.
  • 6Eberhard D A, Johnson B E, Amler L C, et al. Mutations in the epi- dermal growth factor receptor and in KRAS are predictive and prognos- tic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib [ J]. J Clin On- col, 2005, 23 (25) : 5900 - 5909.
  • 7Tsao M S, Sakurada A, Ding K, et al. Prognostic and predictive value of epidermal growth factor receptor tyrosine kinase domain mutation sta- res and gene copy number for adjuvant chemotherapy in non-small cell lung cancer[ J]. J Thorac Oncol. 2011. 6 ( 1 139 - 14.7.
  • 8Fabbro D, Di-Loreto C, Stamerra O, et al. TYF-1 gene expression in human lung tumours[ J]. Eur J Cancer, 1996, 32A(3) : 512 -517.
  • 9Boggaram V. Thyroid transcription factor-1 ( TIT-1/Nkx2. 1/TITF1 ) gene regulation in the lung [ J ]. Clin Sci ( Lond ), 2009, 116 ( 1 ) : 27 - 35.
  • 10Kaufmann O, Dietel M. Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B [ J ]. Histopa- thology, 2000, 36(1): 8-16.

共引文献36

同被引文献40

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部